RPG Life Sciences Limited

RPGLIFE.BO·BSE·Healthcare
Compare
2,583.80−18.55 (−0.71%)today
At close: Nov 5, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,602.35
Open2,616.15
Day range2,575.002,631.00
52-week range1,731.253,130.50
Off day high−1.79%
Off 52-week high−17.46%
Volume550
Avg. volume (3M)1.43K
Market cap42.73B
EPS (TTM)67.01
Forward P/E27.43
P/E ratio (TTM)38.56
Dividend yield0.92% (24.00)
Beta (5Y)-0.05
Shares outstanding16.54M
Short interest—
Earnings dateJul 18, 2025
Analyst target3,205.00
Profit margin16.29%

Against its peers

Compare in full ›
RPGLIFE.BO SOLARA.NS MEGA.BK INDSWFTLAB.BO 1795.TW IOLCP.BO
Market cap 42.73B 31.04B 30.95B 31.50B 44.76B 55.54B
P/E (TTM) 38.6 83.4 14.2 37.0 11.8 27.3
Forward P/E 27.4 20.5 12.4 — 7.1 17.5
Price/book 7.1 2.2 3.0 2.1 1.9 2.9
Dividend yield 0.92% — 4.86% — 1.61% 0.54%
1-year change +3.92% +14.61% +20.69% +239.52% −42.88% +102.42%
Today −0.71% −0.25% +1.43% −4.09% +5.66% +3.08%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Related companies

Compare ›

The stocks whose daily moves over the past year went most closely with RPG Life Sciences's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Gujarat Themis Biosyn LimitedGUJTHEM.BO · Correlation 0.32 50.46B 387.70 0.00%

What visitors to RPG Life Sciences's page also look at.

Company Mkt cap Price Today
GUFIC BIOSCIENCES LTD.GUFICBIO.BO 43.65B 435.25 +2.03%
NEULAND LABORATORIES LTD.NEULANDLAB.BO 250.29B 19,508.70 −0.54%
SMS PHARMACEUTICALS LTD.SMSPHARMA.BO 48.32B 515.95 −1.99%
GRANULES INDIA LTD.GRANULES.BO 192.80B 794.50 −0.01%
AARTI DRUGS LTD.AARTIDRUGS.BO 40.55B 444.30 −2.23%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All RPGLIFE.BO news ›
Moneycontrol··2 outletsPositive

RPG Life Sciences bets on API expansion to drive next growth phase, eyes more acquisitions- Moneycontrol.com

The company, part of the RPG Group, recently carved out its API operations into a separate subsidiary, RPG Active Pharma, and brought in healthcare-focused private equity investor InvAscent as a strategic partner. The PE firm invested…

LLYGOOGL
More from 1 other outlet
Markets Mojo·Positive

RPG Life Sciences Ltd is Rated Hold by MarketsMOJO

MarketsMojo - RPG Life Sciences Ltd is Rated Hold by MarketsMOJO Understanding the Current Rating The 'Hold' rating assigned to RPG Life Sciences Ltd indicates a balanced outlook for investors. It suggests that while the stock may not be…

PEGPCRX
News18·Negative

RPG Life Sciences posts Rs 28.22 cr profit in Q2

New Delhi, Oct 30 (PTI) RPG Life Sciences posted a decline in net profit to Rs 28.22 crore in the September quarter. The RPG Group firm had posted a profit of Rs 36.85 crore in the year-ago period, it said in a regulatory filing on…

From the 4Search news index, newest first.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Mentioned with

Raghava Life Sciences7Rpg Active Pharma7Rpg Life Sciences Ltd6Rpg Group5US Food and Drug5Rpg Life Sciences Limited4Premier Partners3Raghava Life Sciences API3

People in the coverage

Ashok Nair7Naprocin7Norpace7Raghava7Aditi Singhvi4Bhaskar Vishwajeet4

Themes

Raghava Life Sciences7API Manufacturing6Rpg Active Pharma6Actis Generics5Analysis5API Manufacturing India5Healthcare4Earnings3

Most coverage from

  1. tradingview.com2
  2. freepressjournal.in1
  3. livelaw.in1
  4. marketsmojo.com1
  5. moneycontrol.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance